Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Clinical Imbalances

Immune and inflammation

Neurological

Modifiable Lifestyle Factors

Stress, Relaxation, Resilience

Laboratory Testing

Blood

Text Availability

Abstract

152

Full text

116

Free full text

Publication Types

Journal Article

152

Review

100

Research Support, Non-U.S. Gov't

Research Support, N.I.H., Extramural

Case Reports

Research Support, N.I.H., Intramural

Clinical Trial

Meta-Analysis

Multicenter Study

Systematic Review

Randomized Controlled Trial

Clinical Trial, Phase III

Comparative Study

Observational Study

Letter

Clinical Trial, Phase II

Comment

Research Support, U.S. Gov't, P.H.S.

Controlled Clinical Trial

Publication Year

From

Quick links

Individual year

2026

2025

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2006

2005

2004

2003

2002

2001

2000

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Epstein-Barr Virus Infections""[mesh_terms]

156 Results

Searching titles within these results

Targeting EBV-encoded products: Implications for drug development in EBV-associated diseases.

Yuan Ding, Mengwen Lv, Yan Zhang, Shuzhen Liu

Reviews in medical virology 2024;34(1):e2487

Full Text

Abstract

Hydroa vacciniforme: a distinctive form of Epstein-Barr virus-associated T-cell lymphoproliferative disorders.

Keiji Iwatsuki, Tomoko Miyake, Yoji Hirai, Takenobu Yamamoto

European journal of dermatology : EJD 2019;29(1):21-28

Full Text

Abstract

Epstein-Barr virus-associated T-/natural killer cell lymphoproliferative diseases.

Akihiro Yachie, Hirokazu Kanegane, Yoshihito Kasahara

Seminars in hematology 2003;40(2):124-32

Full Text

Abstract

Therapeutic strategy for oncovirus-mediated oral cancer: A comprehensive review.

Rekha Thiruvengadam, Jin Hee Kim

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2023;165():115035

Free Full Text

Abstract

Epidemiology of Multiple Sclerosis: From Risk Factors to Prevention-An Update.

Alberto Ascherio, Kassandra L Munger

Seminars in neurology 2018;36(2):103-14

Full Text

Abstract

Epstein-barr virus infection and multiple sclerosis: a review.

Alberto Ascherio, Kassandra L Munger

Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology 2010;5(3):271-7

Full Text

Abstract

Role of environmental factors in multiple sclerosis.

Suzi B Claflin, Ingrid van der Mei, Bruce V Taylor, Amin Zarghami, Ying Li

Expert review of neurotherapeutics 2022;21(12):1389-1408

Full Text

Abstract

Human Gut Microbiota-associated Gastrointestinal Malignancies: A Comprehensive Review.

Apurva Bonde, Sean Daly, Julia Kirsten, Sainath Kondapaneni, Vincent Mellnick, Christine O Menias, Venkata S Katabathina

Radiographics : a review publication of the Radiological Society of North America, Inc 2021;41(4):1103-1122

Full Text

Abstract

Navigating Epstein-Barr Virus (EBV) and Post-Transplant Lymphoproliferative Disorder (PTLD) in Pediatric Liver Transplantation: Current Knowledge and Strategies for Treatment and Surveillance.

Erin Y Chen, Sara Hassan, Sara Kathryn Smith, Krupa R Mysore, Wikrom Karnsakul, Natasha Dilwali

Viruses 2025;17(2):

Free Full Text

Abstract

Illuminating vitamin D effects on B cells--the multiple sclerosis perspective.

Linda Rolf, Anne-Hilde Muris, Raymond Hupperts, Jan Damoiseaux

Immunology 2016;147(3):275-84

Free Full Text

Abstract

The IPTA Nashville consensus conference on Post-Transplant lymphoproliferative disorders after solid organ transplantation in children: II-consensus guidelines for prevention.

Michael Green, James E Squires, Richard E Chinnock, Patrizia Comoli, Lara Danziger-Isakov, Daniel E Dulek, Carlos O Esquivel, Britta Höcker, Arnaud G L'Huillier, George Vincent Mazariegos, Gary A Visner, Catherine M Bollard, Anne I Dipchand, Judith A Ferry, Thomas G Gross, Robert Hayashi, Britta Maecker-Kolhoff, Stephen Marks, Olivia M Martinez, Diana M Metes, Marian G Michaels, Jutta Preiksaitis, Françoise Smets, Stephen H Swerdlow, Ralf U Trappe, James D Wilkinson, Upton Allen, Steven A Webber, Vikas R Dharnidharka

Pediatric transplantation 2024;28(1):e14350

Full Text

Abstract

The role of human endogenous retroviruses (HERVs) in Multiple Sclerosis and the plausible interplay between HERVs, Epstein-Barr virus infection, and vitamin D.

Tayebeh Latifi, Arghavan Zebardast, Sayed Mahdi Marashi

Multiple sclerosis and related disorders 2022;57():103318

Full Text

Abstract

Targeting the RNA G-Quadruplex and Protein Interactome for Antiviral Therapy.

Li-Yan Zhai, Jing-Fan Liu, Jian-Jin Zhao, Ai-Min Su, Xu-Guang Xi, Xi-Miao Hou

Journal of medicinal chemistry 2022;65(15):10161-10182

Full Text

Abstract

Post-Transplant Lymphoproliferative Disorder Presenting as a Gastrointestinal Fistulous Tract in a Heart Transplant Recipient: Case Report and Literature Review.

Nour Hasan, Ramia Zakhour, Luz Helena Gutierrez Sanchez, Audrey R Lloyd, Geling Li, Clara L Ortiz, Cecelia Hutto

Transplantation proceedings 2024;56(9):2084-2091

Full Text

Abstract

The oncogenic gamma herpesviruses Epstein-Barr virus (EBV) and Kaposi's sarcoma-associated herpesvirus (KSHV) hijack retinoic acid-inducible gene I (RIG-I) facilitating both viral and tumour immune evasion.

Alana Nash, Elizabeth J Ryan

Tumour virus research 2022;14():200246

Free Full Text

Abstract

Results: 1 – 15 / 156

Filters

Expert Opinion

Clinical Imbalances

Modifiable Lifestyle Factors

Laboratory Testing

Text Availability

Publication Types

Publication Year

Results for ""Epstein-Barr Virus Infections""[mesh_terms]

Targeting EBV-encoded products: Implications for drug development in EBV-associated diseases.

Hydroa vacciniforme: a distinctive form of Epstein-Barr virus-associated T-cell lymphoproliferative disorders.

Epstein-Barr virus-associated T-/natural killer cell lymphoproliferative diseases.

Therapeutic strategy for oncovirus-mediated oral cancer: A comprehensive review.

Epidemiology of Multiple Sclerosis: From Risk Factors to Prevention-An Update.

Epstein-barr virus infection and multiple sclerosis: a review.

Role of environmental factors in multiple sclerosis.

Human Gut Microbiota-associated Gastrointestinal Malignancies: A Comprehensive Review.

Navigating Epstein-Barr Virus (EBV) and Post-Transplant Lymphoproliferative Disorder (PTLD) in Pediatric Liver Transplantation: Current Knowledge and Strategies for Treatment and Surveillance.

Illuminating vitamin D effects on B cells--the multiple sclerosis perspective.

The IPTA Nashville consensus conference on Post-Transplant lymphoproliferative disorders after solid organ transplantation in children: II-consensus guidelines for prevention.

The role of human endogenous retroviruses (HERVs) in Multiple Sclerosis and the plausible interplay between HERVs, Epstein-Barr virus infection, and vitamin D.

Targeting the RNA G-Quadruplex and Protein Interactome for Antiviral Therapy.

Post-Transplant Lymphoproliferative Disorder Presenting as a Gastrointestinal Fistulous Tract in a Heart Transplant Recipient: Case Report and Literature Review.

The oncogenic gamma herpesviruses Epstein-Barr virus (EBV) and Kaposi's sarcoma-associated herpesvirus (KSHV) hijack retinoic acid-inducible gene I (RIG-I) facilitating both viral and tumour immune evasion.

Results for
""Epstein-Barr Virus Infections""[mesh_terms]